science
AI agent team identifies a lung-cancer drug candidate
A virtual biotech using up to 37,000 AI agents identified CD276 as a lung-cancer target and proposed an antibody linked to an anticancer drug. The work is at the computational discovery stage, with experimental and clinical validation still ahead.